| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xtant Medical Holdings, Inc. (XTNT) has 8 insiders with recent SEC Form 4 filings, including 8 buys and 9 sells. XTNT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 7.52M | $4.28M | - | |
| CFO | 843.4K | $480.7K | - | |
| CEO | 789.9K | $450.2K | - | |
| COO | 663.2K | $378.0K | - | |
| Dir | 517.6K | $295.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | Orbimed Advisors LLC67 | 10% Owner | Sell | 73,114,592 | $0.42 | $30,708,128.64 | -100% | +71.2% | +26.3% | |
| Nov 17, 2023 | Brandt Kevin D | Chief Commercial Officer | Buy | 41,670 | $1.20 | $49,837.32 | +5.4% | -7.8% | -62.7% | |
| Jan 18, 2023 | Neils Scott C | Chief Financial Officer | Sell | 8,673 | $0.61 | $5,282.72 | -2.1% | +5.7% | +84.1% | |
| Oct 19, 2022 | Browne Sean E | President And CEO | Sell | 131,100 | $0.65 | $85,827.97 | -4.1% | +3.1% | +75.8% | |
| Oct 7, 2022 | Vizirgianakis Stavros G. | Director | Buy | 2,264,861 | $0.48 | $1,087,133.28 | +63.2% | -9.7% | +63.1% | |
| Aug 17, 2022 | Brandt Kevin D | Chief Commercial Officer | Sell | 23,000 | $0.49 | $11,221.73 | -1.6% | +34.0% | +146.8% | |
| Aug 17, 2022 | Neils Scott C | Chief Financial Officer | Sell | 6,370 | $0.48 | $3,065.27 | -0.8% | +34.0% | +146.8% | |
| Feb 14, 2018 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 945,819 | $7.20 | $6,809,896.80 | +11.4% | - | - | |
| Feb 14, 2018 | Rizzo Matthew | Director, 10% Owner | Buy | 945,819 | $7.20 | $6,809,896.80 | +11.4% | - | - | |
| Feb 14, 2018 | Eggenberg Michael | Director, 10% Owner | Buy | 945,819 | $7.20 | $6,809,896.80 | +11.4% | - | - |